- Report
- August 2023
- 116 Pages
Middle East, Africa
From €1311EUR$1,500USD£1,145GBP
- Report
- August 2023
- 213 Pages
Global
From €3146EUR$3,600USD£2,749GBP
- Report
- June 2023
- 224 Pages
Global
From €3146EUR$3,600USD£2,749GBP
- Report
- June 2023
- 182 Pages
Global
From €3146EUR$3,600USD£2,749GBP
- Report
- November 2024
- 150 Pages
Global
From €3365EUR$3,850USD£2,940GBP
€4239EUR$4,850USD£3,704GBP
- Report
- November 2024
- 150 Pages
Global
From €3365EUR$3,850USD£2,940GBP
€4239EUR$4,850USD£3,704GBP
- Report
- September 2024
- 150 Pages
Global
From €3365EUR$3,850USD£2,940GBP
€4239EUR$4,850USD£3,704GBP
- Report
- September 2024
- 150 Pages
Global
From €3365EUR$3,850USD£2,940GBP
€4239EUR$4,850USD£3,704GBP
- Report
- January 2024
- 150 Pages
Global
From €3365EUR$3,850USD£2,940GBP
€4239EUR$4,850USD£3,704GBP
- Report
- January 2024
- 150 Pages
Global
From €3365EUR$3,850USD£2,940GBP
€4239EUR$4,850USD£3,704GBP
- Report
- March 2023
- 150 Pages
Global
From €3365EUR$3,850USD£2,940GBP
€4239EUR$4,850USD£3,704GBP
- Report
- December 2025
- 33 Pages
Australia
From €4366EUR$4,995USD£3,814GBP
- Report
- November 2025
- 27 Pages
Canada
From €4366EUR$4,995USD£3,814GBP
- Report
- November 2025
- 28 Pages
Australia
From €4366EUR$4,995USD£3,814GBP
- Report
- November 2025
- 30 Pages
India
From €4366EUR$4,995USD£3,814GBP
- Report
- November 2025
- 28 Pages
Germany
From €4366EUR$4,995USD£3,814GBP
- Report
- October 2025
- 99 Pages
Kuwait
From €4239EUR$4,850USD£3,704GBP
- Report
- October 2025
- 91 Pages
Oman
From €4239EUR$4,850USD£3,704GBP
- Report
- October 2025
- 98 Pages
Saudi Arabia
From €4239EUR$4,850USD£3,704GBP
- Report
- October 2025
- 82 Pages
Bahrain
From €4239EUR$4,850USD£3,704GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more